{"disease":{"id":"hemangioblastoma-hb-of-the-central-nervous-system-cns","name":"hemangioblastoma hb of the central nervous system cns"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07167329","title":"Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"José Claudio Casali da Rocha","has_results":false},{"nct_id":"NCT02120040","title":"Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}